Benefits of Alcoholic Hangover Medicine

NCT ID: NCT06126094

Last Updated: 2023-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-31

Study Completion Date

2023-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Myrkl is advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. With this research, the investigators want to determine the impact of the mentioned dietary supplement on the intestinal microbiome. For this purpose, the research was designed in three phases before, during and after the research as a double blind trial. In doing so, the subjects take a stool sample before and after the intervention and during the intervention, fill out questionnaires and undergo cognitive tests. At the same time, they give a blood sample after the intervention. After the results of the analysis are due, the researchers enter the data into the for that the predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of statistical analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A "cure" for an alcoholic hangover has been put on the market, that is, it relieves the symptoms and ailments hangover alcohol (https://www.myrkl.com/). This medicine contains probiotic strains in its formulation (Bacillus subtilis, Bacillus coagulans). Myrkl has been advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. The manufacturer claims that after taking Myrkl participants feel fresh even after a "long night". In addition to the probiotics mentioned above, Myrkl also contains L-cysteine and vitamins B12. The formula is said to be activated in the intestines. The manufacturer states that 77 of users are satisfied product and how it is completely natural. It is recommended to take two capsules two hours before consumption alcohol. With this research, the investigators wanted to determine the taxonomic changes within the intestinal microbiome after the intervention. In addition, the investigators wanted to determine changes in the subjective impression of a hangover measured by a validated questionnaires. The research was designed as a double-blind placebo-controlled intervention study twins (controlled for age, sex, cohabitation, genetics).

Before the start of the intervention, the test subjects will be instructed to eat the same diet during the 48 hours before beginning of each intervention. The subjects will keep a food diary for two days in order to accurately evaluated the nutritional status. The key is that both subjects consume the same food in both times before the intervention. The food intake itself is determined by the respondents independently.

After the intervention, the respondents will fill out a selection of questionnaires created in the form using the link a special online document (Project BLAM, Forms, Microsoft, USA) that will evaluate theirs alcoholic hangover. In order to evaluate the dynamics of the hangover, the test subject will again every 2 hours fill out the questionnaire (6 evaluations in total - waking up, 2, 4, 6, 8 and 10 hours after waking up). The result of each questionnaire is obtained by calculating the arithmetic mean of all answers (0-5, 0-10). Using all questionnaire was approved by the publisher and the English version will be used. Questionnaires were used https://forms.office.com/Pages/DesignPageV2.aspx subpage=design\&FormId=hN0190t4UESOZ73jM ACw9LJ5ROlYHHVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u\&Token=fcda6871a b5d4009b779536b561d8dfb :

* Alcohol Hangover Questionnaire (AHQ)
* Alcohol Hangover Severity Scale (AHSS)

Materials The subject of the test will be supplementation with a precise probiotic for hangovers (Myrkl, De Fair

Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of:

* 560 mg of naturally fermented rice bran
* Bacillus subtilis
* B. coagulans
* L-cysteine
* dextrin
* 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate The CFU per strain in the formulation is minimal (ask the manufacturer). The probiotic comes in capsule form blister, stored at room temperature. An 800 mg capsule containing dextrin (maltodextrin) will be used for the placebo. It's a placebo dose also two capsules of 800 mg each.

The recommended intake will be two capsules exactly two hours before alcohol consumption. Control entry will be through a video diary.

Methods Analyzes of the intestinal microbiome Since the impact of probiotics on the intestinal microbiome will be measured before and after the investigated intervention two analyzes of the intestinal microbiome will be carried out on Day 0, i.e. on the day of the start of the intervention and Day 1, the day after the intervention. The BIOMES sampling kit will be used for the analysis, and intest.pro. The analysis will be performed on a sample of the first morning stool that the test subjects will take independently in home conditions Day 0 and Day 1. Samples will be delivered to the company's laboratory by logistics service BOMES (BIOMES GmbH, Wildau, Germany) where next-generation sequencing of 16s will be performed ribosomal RNA and bioinformatic analysis of the results (review of taxonomy and functionality). These results will be delivered to the researchers.

Statistical analysis Statistical data processing will analyze the changes in both test subjects, B1 and B2, taking taking into account whether the intervention was verum (V) or placebo (P). Upon maturity descriptive and inferential statistics will be made of the results using the appropriate program (Statistica, Palo Alto, USA). For normally distributed data, use the Kolmogorov-Smirnoff test will be the average and standard deviation, and for the second group the median and percentiles. To analyze the hypothesis treatment Mann-Whitney test and paired t-test will be used. Statistically significant will be considered p- values less than 0.05.

The research is divided into three phases - before the intervention, intervention, and after interventions. Alcohol is administered during the intervention. The respondents choose the drink they want consumed in two categories: welcome drink - žestice, brandy, liqueur, wormwood, evening drink - gemišt, wine, beer, gin and tonic, juice and juice.

Before intervention:

* the test subjects took the tests and research material at the Sky Office reception
* 48 hours before the intervention, they monitor their diet through a diary
* both test subjects eat absolutely identical food before each intervention
* on Day 0 they take the first stool sample (test A, test C), ideally the morning stool/the first stool
* do not consume any alcohol
* two hours before the planned intervention, say 6:30 p.m., that means around 4:30 p.m. they take a capsule with 1 dl water

Intervention:

* the subjects come to the recording on Day 0 around 18.00 in the CCM area, the conference room
* from 18.00 to 18.30 is preparation for recording
* at 6:30 p.m. the first sip of alcohol follows - a welcome drink (zestica, liqueur)
* around 6:40 p.m. the drinks of the evening follow (gemišt, gin and tonic, beer, wine)
* the first interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
* around 7:00 p.m., the first cut follows - a welcome drink
* around 7:10 p.m., another drink in the evening
* a second conversation follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
* during the second interview, the interviewees have the opportunity to eat something small (meal/sandwich)
* around 19.10 the last drink of the evening goes, possibly. and a welcome drink
* a third interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
* Human Lab takes a blood sample to determine blood ethanol, which CCM employees will take to HKA KBSD same evening immediately

After the intervention:

* after waking up and then within two hours, the subjects fill out the questionnaire: https://forms.office.com/Pages/ResponsePage.aspx?id=hN0190t4UESOZ73jMACw9LJ5ROlYH HVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u
* the morning stool or the first stool after the intervention should be sampled on Day 1
* on Day 1 around 18.00 arrival for filming at the same place
* from 18.00 to 19.00 a conversation about how they feel and whether they think they received a placebo or a probiotic.

After the end of the cycle and the arrival of the results of the analysis, the researchers enter the data into the for that predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of the statistical analysis in the previously explained manner. In these last steps student, research assistants may be involved.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Microbiome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

The test subjects receive capsules of probiotics and palcebo in marked bags and take one or the other arbitrarily without being told what is in which bag. Likewise, the researchers do not know whether the subjects took the probiotic or the placebo.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators
The test subjects receive capsules of probiotics and palceb in marked bags and take one or the other arbitrarily without being told what is in which bag. Likewise, the researchers do not know whether the subjects took the probiotic or the placebo

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotic

Participants will consume 800 mg of probiotic Myrkl before consuming alcohol in the form of one capsule. (Myrkl, De Fair Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of:

* 560 mg of naturally fermented rice bran
* Bacillus subtilis
* B. coagulans
* L-cysteine
* dextrin
* 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate

Group Type EXPERIMENTAL

Myrkl

Intervention Type DIETARY_SUPPLEMENT

The subject of the test will be supplementation with precise probiotic for hangovers (Myrkl, De Fair) in the form of one pill of 800 mg

Placebo

The subject who consumed 800 mg of placebo- dextrin (maltodextrin) in the form of two capsules before consuming alcohol.

Group Type EXPERIMENTAL

dextrin

Intervention Type DIETARY_SUPPLEMENT

The subject of the test will be supplementation with placebo (maltodextrin) in the form of two pills (each 400 mg)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Myrkl

The subject of the test will be supplementation with precise probiotic for hangovers (Myrkl, De Fair) in the form of one pill of 800 mg

Intervention Type DIETARY_SUPPLEMENT

dextrin

The subject of the test will be supplementation with placebo (maltodextrin) in the form of two pills (each 400 mg)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• fraternal twins who live and work together

Exclusion Criteria

* consumption of other probiotics, antibiotics 30 days before the research
* Inability to drink alcohol
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Gut Microbiome Center (Centar za crijevni mikrobiom)

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrija Karačić, dr.med

Role: STUDY_DIRECTOR

Centar za crijevni mikrobiom

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gut Microbiome Center

Zagreb, , Croatia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Croatia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andrija Karačić, dr.med

Role: CONTACT

+385981373344

Ira Renko, MS

Role: CONTACT

+385993373343

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Andrija Karačić, dr.med

Role: primary

+385981373344

Ira Renko, MSC

Role: backup

+385993373343

Related Links

Access external resources that provide additional context or updates about the study.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141364/

Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover Study

https://pubmed.ncbi.nlm.nih.gov/35769391/

Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover Study

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BLAM123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rapid BAC Reduction with Nutraceutical Blend Study
NCT06722898 NOT_YET_RECRUITING PHASE2
Interaction of Alcohol With Energy Drinks
NCT02771587 COMPLETED PHASE1
Combined Effects of Alcohol and Caffeine
NCT01289561 COMPLETED PHASE1
Prevention of Alcohol Intolerance
NCT01845220 COMPLETED PHASE2
Cheers Health Restore Study
NCT07069608 NOT_YET_RECRUITING